Here, we found that recombinant OX40L induce and amplify IL-9 production by human T cells, indicating that the interaction OX40-OX40-L between pDCs and T cells in MS patients could be responsible of the IL-9 induction observed in MS patients. Here, IL9 is linked to myeloid sarcoma.